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Background. Chronic pain (CP) and sleep disorders (SD) are highly prevalent in the general population. However, comprehensive
data regarding the prevalence and characteristics of pain and SD in primary care are rare.Methods. From𝑁 = 578 patients𝑁 = 570
were included within 8 weeks (mean age: 50.8 ± 18.7 years, females: 289). Sociodemographic data, Insomnia Severity Index (ISI),
and parts of a self-report questionnaire for pain (Multidimensional German Pain Questionnaire) were recorded and additional
medical information (pain medication, sleep medication) was gathered from the patient charts. Results. Of the total sample, 33.2%
(𝑛 = 189) suffer from CP (pain ≥ 6 months) and 29.1% (𝑛 = 166) from SD. 45.5% of the CP patients suffer from SD and 26.5%
from clinical insomnia (ISI ≥ 15). SD (𝛽 = 0.872, SE = 0.191, 𝑡 = 4,572, 𝑝 < 0.001, CI [0.497; 1.246]) and older age (𝛽 = 0.025, SE =
0.005, 𝑡 = 5.135, 𝑝 < 0.001, CI [0.015; 0.035]) were significantly associated with pain experience. Conclusion. About a quarter of CP
patients suffer from clinical insomnia.The suggested bidirectional relation should be considered during comprehensive assessment
and treatment of patients.
1. Introduction
Chronic pain (CP) and sleep disorders (SD) have become two
of the most common symptoms reported by primary care
patients. The prevalence of CP ranges from 10 to 40% [1],
which is similar to prevalence rates of SD (10–36% [2–8]). CP
is tied to considerable personal impairment in quality of life
[9, 10]. Due to the high prevalence in the general population
and its prominent disabling nature, CP imposes a burden,
not only for the patient but also for the society in terms
of economic productivity and health care costs [11–14]. The
results of an European cross-sectional survey report that 19%
of CP patients lost their job and 13% had to change their jobs
[15]. These indirect costs (informal caregiving, work impair-
ment, etc.) cause significantly higher expenditures than direct
health care costs alone [16]. Comparable to patients with
CP, patients with SD suffer from poor quality of life and
considerable health restrictions and social limitations [17, 18].
SD are well-documented risk factors for psychiatric diseases
[19–21], cardiovascular diseases [22, 23], and increased mor-
tality [24].
There is limited but growing epidemiological information
on the prevalence of CP and comorbid SD in primary
care. In clinical settings SD have been found to impact
50–88% of CP patients [25, 26]. Vice versa, more than 40%
of patients suffering from SD report CP [4]. Cooccurring
health problems are considered as the norm rather than the
exception in primary care patients [27].They increase the risk
of premature death, hospitalization, loss of physical function-
ing, depression, poly-pharmacy, reduced quality of life, and
increased health care costs [28]. The interaction of sleep and
pain is complex and still not well understood [7]. A recent
meta-analysis confirms a medium effect of sleep deprivation
on pain perception in healthy individuals [29]. However,
the occurrence and size of this effect are unclear in clinical
relevant populations.There is increasing evidence suggesting
a reciprocal relationship between pain and sleep. Results from
studies in animal models [30–33], healthy persons [5, 34–
37], and patients with different types of pain [38–42] support
the reciprocal interaction of CP and SD. For example, phar-
maceutical studies on eszopiclone [43, 44], triazolam [45],
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or pregabalin [46] show a simultaneous improvement of both
pain and sleep.
The presence of comorbid SD in patients with diabetic
peripheral neuropathy and postherpetic neuralgia may even
predict substantial pain relief in response to pain treatment
with pregabalin [47].
Patients with several SD, such as obstructive sleep apnea
syndrome (OSAS) [48] and restless legs syndrome (RLS) [49],
seem to be hyperalgesic. Effective treatment of the respective
sleep disorder improves pain sensitivity. This improvement
has been demonstrated by pharmacological interventions
against pain, such as levodopa (L-DOPA) therapy for RLS
[49], and in nonpharmacological interventions, such as con-
tinuous positive airway pressure (CPAP) treatment for OSAS
[48]. Despite the suspected high prevalence of SD in the
general population, they are often underidentified by primary
care professionals and thus a large percentage of patients
remain untreated [18]. Only in about half of the cases the
treating general practitioner knows about sleeping problems
[50]. Given the significant impact of SD on pain experience
and the fact that pain is a frequent reason for primary care
consultations, the focus of this study was to explore the
prevalence and characteristics of CP and SD in primary
care patients.
2. Methods
2.1. Participants. Participants were patients of a general
practice in Austria. In this practice, patients are treated by
a licensed general physician who underwent a qualifica-
tion programme for psychosomatic and psychotherapeutic
medicine (including, e.g., sleep and pain) at the time of the
study. The practice is the only general practice for a relatively
large rural region where mainly workers and agriculturalists
live.
Within eight-week duration (06/01 to 07/24 2015) every
patient of the general practice was asked to participate. The
study nurses screened all potential participants for their
eligibility and their level of cooperation in order to raise the
responder rate. Subjects who were unable to complete the
questionnaires due to linguistic barriers or serious physical
or psychological health issues and patients younger than 10
years were excluded. After the initial information session all
subjects were provided with questionnaires in the doctor’s
waiting room prior to the consultation. The following ques-
tions regarding pain and sleep disorders were included: “Do
you suffer frompain/sleep disorders?” If this was answered by
“yes” subjects were asked to proceed answering the relevant
questions. In case patients did not know how to answer a
question, the study nurses gave explanations.
2.2. Measures
2.2.1. Pain. Pain was assessed according to the Multidimen-
sional German Pain Questionnaire (Deutscher Schmerz-
fragebogen (DSF) [51]). The items comprised type of pain
(“do you have background pain, background pain with
breakthrough pain, breakthrough pain?”), duration (“since
when do you have pain?”), and localization (“where on your
body do you feel pain?”). CP was defined by pain ≥ 6months.
The instrument is empirically evaluated [52] and also includes
questions concerning age, gender, weight, and height.
2.2.2. Education. Self-reported level of education was
assessed by using 4 response options. We asked for the
highest educational attainment. Employment status was
defined by using a 3-point categorical variable. Job seekers,
person doing family work, and retired persons were assigned
as “unemployed.” We categorized worker, piece worker,
employees, self-employed people, apprentices, volunteers,
and internships as “employed.” Scholars and students were
categorized as “in education.” The specific categories of
education as well as the ones of employment status can be
seen in Table 1.
2.2.3. Medical Information. The current use of prescribed
pain and sleep medication was gathered from the patients’
charts. The coding of the medication as medication for pain
or medication for sleep was done by A.G. According to the
“Pain ladder,” or analgesic ladder, created by theWorldHealth
Organization (WHO) [53], nonopioids (nonsteroidal anti-
inflammatory drugs) and weak opioids were coded as pain
medication. Non-benzodiazepine hypnotics (Z-Drugs), ben-
zodiazepines, and sedating antidepressants (off-label sleep
aids) were coded as sleep medication. If patients were pre-
scribed sleep medication and pain medication together, we
coded as “combinations.”
2.2.4. Sleep Disorders. SD were assessed by the Insomnia
Severity Index (ISI), a brief self-report questionnaire consist-
ing of seven items. Each item has to be rated on a five-point
Likert scale, ranging from 0 (not at all) to 4 (extremely). The
items are problems initiating sleep, problems maintaining
sleep, early awake, satisfaction with current sleep patterns,
impact on daytime quality of life due to SD, noticeabil-
ity of sleep problems by others, distress or worry caused
by SD, and interference with daytime functioning. Total
scores range from 0 to 28. Higher scores indicate a greater
insomnia severity (0–7: no clinically significant insomnia;
8–14: subthreshold insomnia; ≥15: clinical insomnia). The
psychometric properties are considered to be sound [54, 55].
2.3. Source of Funding and Ethical Considerations. The
study was conducted in accordance with the Declaration of
Helsinki and approved by the local ethical committee of the
Danube University of Krems.
Patients were informed about the voluntary nature of
participation and informed consent was obtained from each
subject. If participants were younger than 18 years also par-
ents had to agree.This study was conducted independently of
any institutional influence and was not funded externally.
2.4. Statistics. The statistical analyses were performed with
SPSS 23.0. Frequencies (𝑁, 𝑛), percentages (%), means (M),
and standard deviations (Std) were calculated as descriptive
statistics; Chi-squared tests were performed to compare men
and women. Individuals were excluded from the statistical
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Table 1: Sociodemographic data, body mass index, and pain and sleep medication 𝑛 (%).
Male Female
Gender 𝑛 (%) 281 (49.3) 289 (50.7)
AgeM years (±Std∗) 50.9 (18.6) 50.8 (18.8)
Education% (𝑛)#
Compulsory school 9 years
𝑛 = 181
63 (34.8) 118 (65.2)
Apprenticeship Compulsory school and additional training
of at least 2 years in a specific occupational scope
𝑛 = 276
162 (58.7) 114 (41.3)
Matriculation equal a higher school graduation
𝑛 = 60
31 (51.7) 29 (48.3)
University, University of Applied Science
𝑛 = 51
24 (47.1) 27 (52.9)
Employment status 𝑛 (%)+
Unemployed/retired
𝑛 = 209
109 (52.2) 100 (47.8)
Employed
𝑛 = 306
146 (47.7) 160 (52.3)
In education
𝑛 = 45
23 (51.1) 22 (48.9)
BMI Mean (±Std∗)
𝑛 = 568
27.1 (4.7) 26.2 (5.3)
Medication 𝑛 (%)−
None
𝑛 = 387
201 (51.9) 186 (48.1)
Pain
𝑛 = 129
61 (47.3) 68 (52.7)
Sleep
𝑛 = 31
11 (35.5) 20 (64.5)
Combinations
𝑛 = 18
5 (27.8) 13 (72.2)
∗Standard deviation (Std). #Education was available for 𝑛 = 568 patients (99.6% of total sample). +Employment status was available for 𝑛 = 560 patients (98.2%
of total sample). −Medication was available for 𝑛 = 565 patients (99.1% of total sample).
analysis of a variable if they had a missing value in this given
variable.
We modeled predictors for pain experience and sleep
disturbance with type III generalized linear models (GLM).
We used standard stepwise backward model selection pro-
cedures based on AICc [56] for identification of predictor
variables.The backwardmethod and not the forwardmethod
was selected because the forward method has a higher Type
II error risk [57].
3. Results
3.1. Sample. A total of 𝑁 = 570 (𝑁 = 289 female)
patients participated in the study. This equals a response rate
of 98.6%. The mean (Std) age was 50.8 (±18.7), for women
50.8 (±18.8) and for men 50.9 (±18.6) years. The majority
attended compulsory school and apprenticeship (80.2% of
the total sample). About half of the patients were employed
(53.7% of total sample). The mean of the body mass index in
both genders is slightly increased. Not medicated were 67.9%,
22.6% took medications for pain, 5.4% received medication
for sleep, and 3.2% were medicated for both pain and sleep.
Further results for pain are summarized in Table 2. Detailed
data are presented in Table 1.
3.2. Clinical Variables
3.2.1. Pain. Of the total sample 𝑛 = 238 (41.8%) answered yes
to the question “do you suffer from pain?” indicating pain
experiences (41.3% of the men versus 42.2% of the women;
𝑝 = 0.82). Pain duration of at least 6 months (CP) was
reported by 𝑛 = 189 (33.2% of total sample; see Table 2).
3.2.2. Sleep. One hundred and sixty-six patients of the total
sample (29.1%) answered yes to the question “do you suffer
from sleep disorders?” (25.6% of the men versus 32.5% of the
women; 𝑝 = 0.04) and 𝑛 = 33 (5.8%) of the total sample
suffered from a clinical insomnia (see Table 3). Of the 𝑛 = 189
patients with CP, 𝑛 = 86 patients (45.5%) also reported SD.Of
the 𝑛 = 86 patients with CP and SD, 𝑛 = 83 also completed
the ISI and 𝑛 = 22 (26.5% of 𝑛 = 83) had a clinical insomnia
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Table 2: Pain.
% of total sample
(𝑁 = 570)
% of sample with
pain experiences
(𝑛 = 238)
Male (𝑛, %% of the
𝑛 given in the left
column)
Female (𝑛, %% of the
𝑛 given in the left
column)
𝑝 value for the
comparison men
versus women
Type of pain∗
Background pain
𝑛 = 85
14.9 37.6 40 (47.1) 45 (52.9)
𝑝 = 0.89
Background pain with
breakthrough pain
𝑛 = 17
3.0 7.5 9 (52.9) 8 (47.1)
Breakthrough pain
𝑛 = 124
21.8 54.9 61 (49.2) 63 (50.8)
Duration of pain#
Less than 1 month
𝑛 = 17
3.0 7.2 13 (76.5) 4 (23.5)
𝑝 = 0.31
One to six months
𝑛 = 29
5.1 12.3 13 (44.8) 16 (55.2)
Six to twelve months
𝑛 = 12
2.1 5.2 6 (50.0) 6 (50.0)
One to two years
𝑛 = 32
5.6 13.6 16 (50.0) 16 (50.0)
Two to five years
𝑛 = 41
7.2 17.4 20 (48.8) 21 (51.2)
More than 5 years
𝑛 = 104
18.2 44.3 47 (45.2) 57 (54.8)
Localization of pain+
Head
𝑛 = 18
3.2 7.9 4 (22.2) 14 (77.8)
𝑝 = 0.02
Chest
𝑛 = 6
1.1 2.6 5 (83.3) 1 (16.7)
Abdominal
𝑛 = 2
0.4 0.9 2 (100.0) 0 (0)
Back
𝑛 = 51
8.9 22.5 30 (58.8) 21 (41.2)
Joints
𝑛 = 56
9.8 24.7 29 (51.8) 27 (48.2)
Multiple
𝑛 = 94
16.5 41.4 42 (44.7) 52 (55.3)
∗Type of pain was available for 𝑛 = 226 patients (95.0% of the 𝑛 = 238 patients with pain experiences). #Duration of pain was available for 𝑛 = 235 patients
(98.7% of the 𝑛 = 238 patients with pain experiences). +Localization of pain was available for 𝑛 = 227 patients (95.4% of the 𝑛 = 238 patients with pain
experiences).
(ISI ≥ 15). Table 3 provides an overview for the patients with
self-reported sleep disorders.
3.3. General Linear Model. We include 567 individuals in
the full model. The full model includes age, gender, BMI,
employment status, education and sleep disturbances as
correlates of experience of pain. After the stepwise reduction
of variables the final model includes age (𝐹1, 567 = 29.123,
𝑝 < 0.001) and SD (𝐹2, 567 = 20.903, 𝑝 < 0.001). SD was
significantly associated with pain experiences (𝛽 = 0.872, SE
= 0.191, 𝑡= 4,572, 𝑝 < 0.001, CI [0.497; 1.246]).
Older age was associated with pain experience also
significantly (𝛽 = 0.025, SE = 0.005, 𝑡 = 5.135, 𝑝 < 0.001, CI
[0.015; 0.035.]).
4. Discussion
This study underlines the high prevalence of CP and SD in
primary care. 33.2. % suffered fromCP. Out of all participants
29.1% reported SD. 26.5%ofCPpatients suffered fromclinical
insomnia. These findings confirm results from previous
studies [4, 36]. In contrast, several studies indicate a higher
rate of SD in pain patients [40, 58]. These differences can
be partially explained by the different types of pain (pain
experienced in the last four weeks versus CP). This could be
supported by Fishbain and colleagues [59], who showed that
SD are significantly more prevalent in CP patients than in
patients with acute pain.
In our study SD and older age were significantly associ-
ated with pain as already reported [60]. Employment status
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Table 3: Sleep.
% of total sample
(𝑁 = 570)
% of sample with
sleep disorders
(𝑛 = 166)
Male (𝑛, % of the 𝑛
given in the left
column)
Female (𝑛, % of the
𝑛 given in the left
column)
𝑝 value for the
comparison men
versus women
CP and SD
n = 86 15.1 51.8 39 (45.3) 47 (54.7) 𝑝 = 0.33
CP, SD, and problems falling
asleep (ISI item 1 answered as
mild, moderate, severe, or very
severe)
n = 64
11.2 38.6 27 (42.2) 37 (57.8) 𝑝 = 0.18
CP, SD, and problems
maintaining sleep (ISI item 2
answered as mild, moderate,
severe, or very severe)
n = 66
11.6 39.8 30 (45.5) 36 (54.5) 𝑝 = 0.49
CP, SD, and early awaking (ISI
item 3 answered as mild,
moderate, severe, or very severe)
n = 52
9.1 31.3 25 (48.1) 27 (51.9) 𝑝 = 0.85
CP, SD, and sleep dissatisfaction
(ISI item 4 answered as
dissatisfied and very dissatisfied)
n = 31
5.4 18.7 13 (41.9) 18 (58.1) 𝑝 = 0.43
CP, SD, and impact of sleep
disorder on performance (ISI
item 7 answered as a little,
somewhat, much, very much)
n = 76
13.3 45.8 34 (44.7) 42 (55.3) 𝑝 = 0.34
CP, SD, and impact on other life
areas (ISI item 5 answered as a
little, somewhat, much, very
much)
n = 68
11.9 41.0 32 (47.1) 36 (52.9) 𝑝 = 0.69
CP, SD, and worries (ISI item 6
answered as a little, somewhat,
much, very much)
n = 62
10.9 37.3 32 (51.6) 30 (48.4) 𝑝 = 0.79
Clinical insomnia (ISI ≥ 15)
n = 33# 5.8 20.8 16 (48.5) 17 (51.5) 𝑝 = 0.41
CP and Clinical insomnia (ISI ≥
15)
n = 22
3.9 13.3. 11 (50.0) 11 (50.0) 𝑝 = 0.72
#ISI score was available for n = 159 of the n = 166 patients with sleep disorders.
and education were not significantly correlated with pain.
These results are not in line with earlier studies [61–63]. One
possible reason might be the sample characteristics covered
by the study. Our participants showed lower education
attainments [64] and a higher unemployment rate [65] than
Austria as a whole.
We found a higher prevalence in patients suffering from
initiating sleep, maintaining sleep, early awake, and dissat-
isfaction with sleep in comparison to Baker et al. [60]. The
most likely reasons for these differences might be that we
considered longer durations of pain.
The results did not confirm existing evidence, that women
experience chronic pain more often than men [66, 67]. As a
recent systematic review and meta-analysis revealed, chronic
pain prevalence estimations are an obvious matter of survey
methods [68]. Our defining of CP (≥6 month) and data
collection method might explain these differences. We found
no differences in the prevalence of pain type by gender [69].
Male and female patients suffered around the same frequency
from background pain, background pain with breakthrough
pain, and breakthrough pain.We found gender differences in
pain sites.Themost common body sites in women affected by
pain were 1st multiple sites, 2nd joint pain, 3rd back pain, 4th
headache, and 5th chest pain.Men reportedmost frequent 1st
multiple site pain, 2nd back pain, 3rd joints pain, 4th chest
pain, 5th headache, and 6th abdominal pain. These results
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confirmfindings from a recent Austrian study [62] that found
comparable frequencies. Our result revealed that headache is
significantly more common in women [62, 67].
SD are often overlooked in CP patients [70]. This is
especially intriguing as treating cooccurring SD has a high
potential to improve pain management outcomes [71]. About
half of CP patients with SD in our study were prescribed with
pain medication, about 10% to 20% with sleep medication or
combinations of both. Female patients received more often
sleep medications or both, sleep and pain medications. In
clinical practice it would be beneficial to pharmacologically
treat CP and SD jointly [7, 72]. There are several pharmaco-
logical approaches that can improve bothCP and cooccurring
SD. Some tricyclic antidepressants (amitriptyline, nortripty-
line, trimipramine, and doxepin) show positive effects on
both, CP and SD [16, 35, 40, 73, 74]. Trazodone, a serotonin
modulator, has been studied in patients with various types of
pain. The outcome was associated with both improved sleep
quality and pain reduction [25]. Mirtazapine is effective in
the treatment of SD [32] as well as for the treatment of pain
[15, 71].
Gabapentin and pregabalin are also often used to treat
CP and cooccurring SD [60, 75, 76]. Short term use of
benzodiazepines (BRA) [45, 75, 77] and non-benzodiazepine
drugs (NBRA) [43, 44, 78] has been shown to be potentially
useful in improving SD in CP patients. In contrast to benzo-
diazepines [74], long- term efficacy trials have supported the
use of NBRA [76, 79, 80].
A variety of psychological interventions have been found
to be effective in both pain treatment [81–84] and insom-
nia treatment [73, 85]. Psychological techniques for CP
management usually involve strategies for the identification
of dysfunctional and/or maladaptive thoughts and specific
strategies, such as distraction techniques, relaxation training,
and activity pacing.These skills help patients to manage pain
symptoms [70]. Psychological interventions for SD typically
utilize behavioral interventions like general sleep education,
stimulus control instructions, sleep hygiene education, alter-
nation of biorhythm, and sleep restriction [71]. Given the
effectiveness of these interventions, there has been growing
interest in simultaneous treatments of the symptoms. Com-
bined treatments utilize components of both interventions.
In a pilot study with CP patients, Tang and colleagues [86]
found a greater improvement in sleep after treatment, in
comparison to a waiting group, who kept pain and sleep
diaries.
The results of our study have to be interpreted with
respect to its limitations. The generalizability of the results is
limited as only one general practice took part in the study.
Yet, some aspects speak for the generalizability of the results.
First, patients were treated under the conditions of routine.
Second, the practice is the only general practice in a relatively
large rural region. Moreover, it is important to note that the
sample is based on a cross-sectional design, which does not
allow causal inferences.
Additionally, we did not assess psychiatric conditions,
which are frequently associated with SD and pain [87, 88].
Another limitation is thatwe did not carry out comprehensive
assessment of pain and sleep disorders. For example, the
screening question “do you suffer frompain/sleep disorders?”
was not validated before and it is not clear how children
understood the questions. However, only two participants
were younger than 15 years and it has been shown that even
children five years old can give meaningful self-reports of
pain when age-appropriate tools and training are provided
[89]. While the present study has limitations, the results are
based on a relatively large sample size with an extraordinary
high response rate. Thus we can provide an almost complete
evaluation of the cooccurrence of SD and pain experiences in
patients of a general practice.
Comprehensive management of CP and SD in primary
care requires an individualized assessment and treatment
approach. A shift from predominantly biomedical strategies
to a more biopsychosocial perspective would raise treatment
outcomes. SD should be systematically evaluated in CP
patients in primary care settings based on the reported high
cooccurrence. A proactive diagnostic approach for these
persons is needed to achieve accurate information and treat-
ment. Coordinated multidisciplinary and interdisciplinary
care has a high potential to provide this.Thehigh influence on
personal life-quality and health care costs make it important
that increased efforts in experimental and clinical research
are made. The aim of these efforts should be a translationally
meaningful understanding of the mutual impact of CP and
poor sleep.
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